MVT Receives $1.7M Grant from National Heart, Lung, and Blood Institute of Health

MVT
Mar 29, 2018
1 min read

Microvascular Therapeutics (MVT), a Tucson based biotechnology company, announced that it has been awarded a $1.7M grant from the National Heart, Lung, and Blood Institute of the National Institutes of Health.

Recent Posts

See All

Positive Clinical Trial Results with Lead Candidate, CardiSon (MVT-100)

May 14th, 2025 Salt Lake City, Utah: Microvascular Therapeutics, Inc. (MVT), a biotechnology company, announced that it has completed...

Microvascular Therapeutics and Cordance Medical Announce Strategic Partnership

Tucson, AZ & Mountain View, CA – Microvascular Therapeutics (MVT), a pioneering healthcare research and development company, is pleased...

MVT and Soundjet Announce Collaboration Aiming to Bring New Treatment Options to Patients with Vascular Thrombosis

Microvascular Therapeutics, Inc. (MVT), and SoundJet Medical, Inc. (SoundJet) announce that they have entered into a strategic...

Comments

Commenting on this post isn't available anymore. Contact the site owner for more info.